Farzaneh Bozorg-Ghalati

Farzaneh Bozorg-Ghalati

Auto-generated profile, based on publicly available information

Farzaneh Bozorg-Ghalati

Department of clinical biochemistry, school of medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2017 in Current Molecular Medicine
Verified
Journal Article
Closed access
PDF file
FBF. Bozorg-Ghalati
F. Bozorg-Ghalati
MHMehdi Hedayati
Mehdi Hedayati
Anaplastic thyroid carcinoma is the rarest but extremely aggressive thyroid cancer subtype. This neoplasia is composed of undifferentiated tumor cells with poor prognosis and resistant to common thyroid cancer therapy. Early stage identification of this cancer for prompt treatment is very vital. Presently, cytological evaluation of fine needle aspiration biopsy (FNAB) which is known as invasive recognition assay, is the standard diagnostic method for the diagnosis of malignant thyroid tumors. Frequent studies have suggested that using the molecular biomarkers of thyroid cancer tissue alongside cytological examination, increase the accuracy of diagnostic tests. Also, these agents could be beneficial for effective target therapy and personalize medicine. In this review, the molecular biomarkers that are involved in anaplastic thyroid carcinoma in four category (gene mutation profile, epigenetic profile, microRNA profile and cancer stem cell markers) were summarized.

1 January 2024 in Iranian Biomedical Journal
Verified
Journal Article
Open access
PDF file
MZMozhdeh Zamani
Mozhdeh Zamani
FBFarzaneh Bozorg-Ghalati
Farzaneh Bozorg-Ghalati
PMpooneh mokarram
pooneh mokarram
Background: The surface properties of dental and orthopedic implants are directly related to their osseointegration rate. Coating and/or modifying the implant surface might reduce the time of healing. In this study, we aimed to examine the effects of a hybrid surface consisting of a brushite surface coating and cross-linked water-soluble eggshell membrane protein ...

22 December 2017 in Comparative Clinical Pathology
Verified
Journal Article
Closed access
PDF file
FBFarzaneh Bozorg-Ghalati
Farzaneh Bozorg-Ghalati
IMIraj Mohammadpour
Iraj Mohammadpour
RRReza Ranjbaran
Reza Ranjbaran

24 November 2025 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
DMDanial Mohammadpour
Danial Mohammadpour
FGFarhad Ghorbani
Farhad Ghorbani
FBFarzaneh Bozorg-Ghalati
Farzaneh Bozorg-Ghalati
IMIraj Mohammadpour
Iraj Mohammadpour
Surgical site infections raise the risk of serious health issues following oral and maxillofacial surgeries. There is full consensus that using systemic antibiotics as a prophylactic measure can reduce infection risk in oral and maxillofacial surgical procedures, but the optimal duration and effective usage of these antibiotics remains debated. In light of growing antibiotic resistance, prophylactic use of antibiotics should be evaluated carefully and limited to certain scenarios. Thus, the aim of this scoping review was to summarize the available data regarding the prudent and evidence-based application of prophylactic antibiotics in the realm of oral and maxillofacial surgical interventions. A comprehensive literature search was conducted using published studies from 2000 to 2025 across the Ovid MEDLINE, PubMed, Web of Science, Embase, and Google Scholar databases. We included 25 randomized controlled trials, 60 cohort studies, and 40 systematic reviews. According to the included articles, infection rates ranged from 0% to 62% depending on surgery type. Moreover, various antibiotic types and regimens were used, and in most studies, the follow-up period was short, and the outcomes were not clearly defined. The choice of prophylactic antibiotics depends on the specific surgical procedure and the level of contamination involved. The use of prophylactic antibiotics is advised for surgical extractions of third molars, temporomandibular joint replacements, and clean-contaminated tumor removal surgeries. In compound fractures of the mandible, maxillofacial fractures, and those communicating with paranasal sinuses, prescribing a postoperative course of antibiotics for at least 24 h is necessary, but extended use doesn’t lower infection rates. For dental implants, the evidence supporting prophylaxis in healthy individuals is weak. Prophylactic antibiotics are not routinely advised for fractures of the upper or midfacial thirds. The included studies exhibited substantial differences in design and objectives, making direct comparisons challenging. The findings underscore the importance of short-course, targeted prophylaxis over prolonged empirical regimens to curb resistance. Attention to antimicrobial stewardship and strict adherence to guidelines for antibiotic prophylaxis in oral and maxillofacial surgery are essential to reduce antibiotic misuse and improve the quality of study. More studies are required to provide recommendations for maxillofacial surgical interventions in immunocompromised patients.


16 June 2017 in Comparative Clinical Pathology
Verified
Journal Article
Closed access
PDF file
FBFarzaneh Bozorg-Ghalati
Farzaneh Bozorg-Ghalati
MHMehdi Hedayati
Mehdi Hedayati
MDMehdi Dianatpour
Mehdi Dianatpour